艾米克斯生物制药 IMMX
$8.06 +$0.86 (+11.94%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $7.99 -0.87%
开盘$7.24
昨收$7.20
当日区间$7.16 – $8.17
成交量1.44M
市值$669.62M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$12.46M-85.4% YoY
净利润-$11.56M-74.5% YoY
摊薄每股收益-$0.18+18.2% YoY
自由现金流-$11.76M-116.2% YoY
经营现金流-$11.74M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-34.2%
资产收益率-31.3%
投入资本回报率-34.9%
流动比率25.13
负债/资产比率4.3%
现金及投资$232.11M
总负债$890,638.00
净现金（净负债）$231.22M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $12.46M | $10.80M | $29.96M | $10.89M | $7.66M |
| 销售及管理费用 | $7.12M | $4.82M | $13.70M | $5.17M | $3.08M |
| -管理费用 | $7.12M | $4.82M | $13.70M | $5.17M | $3.08M |
| 研发费用 | $5.33M | $5.98M | $16.26M | $5.73M | $4.58M |
| 营业利润 | -$12.46M | -$10.80M | -$29.96M | -$10.89M | -$7.66M |
| 非经营性利息净收入（支出） | $913,663.00 | $717,168.00 | $555,526.00 | $216,712.00 | $84,539.00 |
| 非经营性利息收入 | $913,663.00 | $717,168.00 | $555,526.00 | $216,712.00 | $84,539.00 |
| 税前利润 | -$11.54M | -$10.09M | -$29.40M | -$10.68M | -$7.58M |
| 税费 | $14,322.00 | $0.00 | $37,724.00 | $11,266.00 | $7,722.00 |
| 净利润 | -$11.56M | -$10.09M | -$29.44M | -$10.69M | -$7.59M |
| 持续经营利润 | -$11.56M | -$10.09M | -$29.44M | -$10.69M | -$7.59M |
| 归属母公司净利润 | -$11.56M | -$10.09M | -$29.44M | -$10.69M | -$7.59M |
| 归属普通股股东净利润 | -$11.56M | -$10.09M | -$29.44M | -$10.69M | -$7.59M |
| 基本每股收益 | -$0.18 | -$0.18 | -$0.89 | -$0.28 | -$0.24 |
| 摊薄每股收益 | -$0.18 | -$0.18 | -$0.89 | -$0.28 | -$0.24 |
| 少数股东权益 | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $239.11M | $95.82M | $104.84M | $104.84M | $20.08M |
| 流动资产合计 | $233.79M | $92.27M | $101.24M | $101.24M | $16.58M |
| 现金及现金等价物与短期投资 | $232.11M | $90.58M | $100.41M | $100.41M | $15.95M |
| -现金及现金等价物 | $225.49M | $79.25M | $93.93M | $93.93M | $15.95M |
| -短期投资 | $6.62M | $11.33M | $6.48M | $6.48M | – |
| 预付资产 | $1.40M | $1.36M | $677,608.00 | $677,608.00 | $504,208.00 |
| 其他流动资产 | $279,172.00 | $335,739.00 | $150,721.00 | $150,721.00 | $132,764.00 |
| 非流动资产合计 | $5.32M | $3.54M | $3.60M | $3.60M | $3.50M |
| 固定资产净值 | $3.25M | $3.36M | $3.49M | $3.49M | $3.36M |
| -固定资产原值 | $3.72M | $3.74M | $3.78M | $3.78M | $3.61M |
| -累计折旧 | -$475,571.00 | -$384,579.00 | -$293,001.00 | -$293,001.00 | -$240,888.00 |
| 投资及预付款 | $2.05M | – | – | – | – |
| 一年以上递延资产 | $0.00 | $164,723.00 | $93,630.00 | $93,630.00 | $111,689.00 |
| 其他非流动资产 | $20,418.00 | $20,418.00 | $20,418.00 | $20,418.00 | $20,418.00 |
| 负债合计 | $10.19M | $11.45M | $11.04M | $11.04M | $11.82M |
| 流动负债合计 | $9.30M | $10.54M | $10.11M | $10.11M | $10.85M |
| 应付款 | $5.28M | $4.73M | $5.44M | $5.44M | $7.05M |
| -应付账款 | $5.28M | $4.73M | $5.44M | $5.44M | $7.05M |
| 一年内应计费用 | $3.74M | $4.80M | $3.59M | $3.59M | $3.22M |
| 短期债务及融资租赁负债 | $111,114.00 | $125,392.00 | $139,339.00 | $139,339.00 | $141,282.00 |
| -一年内到期融资租赁负债 | $111,114.00 | $125,392.00 | $139,339.00 | $139,339.00 | $141,282.00 |
| 非流动负债合计 | $890,638.00 | $912,343.00 | $933,625.00 | $933,625.00 | $965,053.00 |
| 长期债务及融资租赁负债 | $890,638.00 | $912,343.00 | $933,625.00 | $933,625.00 | $965,053.00 |
| -长期融资租赁负债 | $890,638.00 | $912,343.00 | $933,625.00 | $933,625.00 | $965,053.00 |
| 股东权益合计 | $228.92M | $84.36M | $93.80M | $93.80M | $8.26M |
| 股东权益 | $228.92M | $84.36M | $93.80M | $93.80M | $8.26M |
| 股本 | $7,160.00 | $5,307.00 | $5,301.00 | $5,301.00 | $3,311.00 |
| -普通股 | $7,160.00 | $5,307.00 | $5,301.00 | $5,301.00 | $3,311.00 |
| 资本公积 | $355.00M | $198.90M | $198.29M | $198.29M | $102.07M |
| 留存收益 | -$126.11M | -$114.55M | -$104.46M | -$104.46M | -$93.78M |
| 减：库存股 | $99,963.00 | $99,963.00 | $99,963.00 | $99,963.00 | $99,963.00 |
| 不影响留存收益的损益 | $118,720.00 | $105,636.00 | $60,160.00 | $60,160.00 | $62,464.00 |
| 应收款 | – | – | $0.00 | $0.00 | $0.00 |
| -应收税款 | – | – | $0.00 | $0.00 | $0.00 |
| 少数股东权益 | – | – | $0.00 | $0.00 | $0.00 |
| -优先股 | – | – | – | – | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$11.74M | -$9.83M | -$23.93M | -$11.03M | -$5.91M |
| 持续经营经营活动现金流净额 | -$11.74M | -$9.83M | -$23.93M | -$11.03M | -$5.91M |
| 持续经营净利润 | -$11.56M | -$10.09M | -$29.44M | -$10.69M | -$7.59M |
| 持续经营损益 | -$38,683.00 | $23,505.00 | – | – | – |
| 折旧、折耗与摊销 | $130,884.00 | $130,766.00 | $364,501.00 | $90,631.00 | $134,855.00 |
| 营运资金变动 | -$1.25M | -$470,342.00 | $2.70M | -$1.00M | $1.07M |
| -应收款变动 | $725.00 | -$725.00 | $2.06M | $12,379.00 | $21,564.00 |
| -预付资产变动 | $12,044.00 | -$866,595.00 | -$286,729.00 | -$191,348.00 | $50,572.00 |
| -应付账款及应计费用变动 | -$1.23M | $432,207.00 | $1.03M | -$790,864.00 | $1.04M |
| -其他流动负债变动 | -$35,983.00 | -$35,229.00 | -$98,006.00 | -$33,371.00 | -$32,667.00 |
| 投资活动现金流净额 | $2.67M | -$4.80M | -$7.21M | -$6.65M | -$372,456.00 |
| 持续经营投资活动现金流净额 | $2.67M | -$4.80M | -$7.21M | -$6.65M | -$372,456.00 |
| 固定资产购置及出售净额 | -$21,043.00 | -$32,486.00 | -$732,925.00 | -$165,126.00 | -$372,456.00 |
| 投资购置及出售净额 | $2.69M | -$4.77M | -$6.48M | – | – |
| 筹资活动现金流 | $155.28M | -$37,561.00 | $107.39M | $95.67M | $10.61M |
| 持续经营筹资活动现金流净额 | $155.28M | -$37,561.00 | $107.39M | $95.67M | $10.61M |
| 股票期权行使所得 | $452,362.00 | $33,532.00 | $131,142.00 | $124,802.00 | $516.00 |
| 期末现金余额 | $225.49M | $79.25M | $93.93M | $93.93M | $15.95M |
| 现金净变动 | $146.22M | -$14.67M | $76.24M | $77.99M | $4.33M |
| 期初现金余额 | $79.25M | $93.93M | $17.68M | $15.95M | $11.64M |
| 汇率变动影响 | $24,665.00 | -$12,813.00 | $3,842.00 | -$11,745.00 | -$20,552.00 |
| 自由现金流 | -$11.76M | -$9.86M | -$24.66M | -$11.19M | -$6.28M |
| 其他筹资费用净额 | – | -$71,093.00 | -$136,999.00 | $29,756.00 | – |
| -其他流动资产变动 | – | – | $0.00 | $0.00 | – |
| 普通股发行净额 | – | – | $107.39M | $95.51M | $10.77M |
暂无评论——快来第一个聊聊 IMMX。
登录后参与讨论。